TickerFacts.

Aptevo Therapeutics Inc. (APVO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$21.05M
Year ended 2022-12-31
2015-12-31: -$50.29M2016-12-31: -$39.37M2017-12-31: -$42.98M2018-12-31: -$52.40M2019-12-31: -$42.54M2020-12-31: -$29.41M2021-12-31: -$22.39M2022-12-31: -$21.05M-$21.05M
2015-12-31 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$21.05Mn/m2024-03-05, From 2022-01-01
2021-12-31-$22.39Mn/m2023-03-30, From 2021-01-01
2020-12-31-$29.41Mn/m2022-03-24, From 2020-01-01
2019-12-31-$42.54Mn/m2021-03-31, From 2019-01-01
2018-12-31-$52.40Mn/m2020-03-25, From 2018-01-01
2017-12-31-$42.98Mn/m2019-03-18, From 2017-01-01
2016-12-31-$39.37Mn/m2018-03-13, From 2016-01-01
2015-12-31-$50.29Mn/a2017-03-31, From 2015-01-01